COMMUNIQUÉS West-GlobeNewswire

Yield10 Bioscience, Inc. to Present at the Ladenburg Thalmann Technology Expo 2019 on May 30, 2019
28/05/2019
WOBURN, Mass., May 28, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN), an agricultural bioscience company which uses its “Trait Factory” to develop high value seed traits for the agriculture and food [...]
Corvus Pharmaceuticals to Present at the Jefferies 2019 Global Healthcare Conference
28/05/2019
BURLINGAME, Calif., May 28, 2019 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted [...]
Wildflower Featured in NetworkNewsWire Publication Highlighting Heightened Media Coverage of CBD Products
28/05/2019
NEW YORK, May 28, 2019 (GLOBE NEWSWIRE) -- via NetworkWire — Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial [...]
MyoKardia Presents Results from Phase 1a Clinical Trial of MYK-491 at the European Society of Cardiology Heart Failure Congress in Athens, Greece
28/05/2019
First-in-Human Data for MYK-491 in Healthy Volunteers Demonstrated Well-Tolerated Increases in Cardiac Contractility Topline Results from Phase 2a Clinical Trial of MYK-491 in Patients with Stable Heart Failure with [...]
Wildflower mise en avant dans la publication de NetworkNewsWire soulignant la couverture médiatique accrue des produits à base de CBD
28/05/2019
NEW YORK, 28 mai 2019 (GLOBE NEWSWIRE) -- via NetworkWire — Wildflower Brands Inc. (CSE : SUN) (OTCQB : WLDFF) a annoncé aujourd'hui son apparition dans une rubrique éditoriale publiée par NetworkNewsWire (« NNW »), une [...]
PDS Biotechnology to Present at the 9th Annual LD Micro Invitational
28/05/2019
BERKELEY HEIGHTS, N.J., May 28, 2019 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (“PDS Biotechnology”) (Nasdaq: PDSB), a clinical-stage immuno-oncology company pioneering the development of novel multifunctional [...]
AIT Therapeutics Presents On-Demand Nitric Oxide Study and Poster at the International Society for Aerosols in Medicine 2019 Congress in Montreux, Switzerland
28/05/2019
GARDEN CITY, N.Y. and REHOVOT, Israel, May 28, 2019 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (NASDAQ: AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO [...]
Cassava Sciences Announces New Website Launch
28/05/2019
AUSTIN, Texas, May 28, 2019 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company, announced today the launch of its newly designed website, www.CassavaSciences.com . Cassava [...]
Treos Bio Announces Positive Interim Results from a Phase 1/2 Clinical Trial of Precision Cancer Vaccine Plus Maintenance Therapy in Patients with Metastatic Colorectal Cancer
28/05/2019
Study will be presented in poster session at the 2019 ASCO Annual Meeting LONDON, May 28, 2019 (GLOBE NEWSWIRE) -- Treos Bio Limited, an immuno-oncology company developing next-generation, precision cancer vaccines [...]
Corcept Therapeutics to Present Data from Phase 1/2 Trial of Relacorilant Plus Nab-Paclitaxel in Patients with Solid Tumors at the American Society of Clinical Oncology Annual Meeting
28/05/2019
MENLO PARK, Calif., May 28, 2019 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs that treat severe metabolic, oncologic [...]
Avid Bioservices to Participate at BIO International Convention 2019
28/05/2019
-- Company to Provide Insight on Key CDMO Industry Topics through Podium Presentation, Panel Discussion and Executive Interview as Part of Convention’s BioProcess International Theater -- -- Corporate Booth to Highlight [...]
Tyme Technologies to Present at the Jefferies 2019 Global Healthcare Conference on June 7, 2019
28/05/2019
NEW YORK, May 28, 2019 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME) , an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that management will present at the [...]
Matinas BioPharma Announces Publication of MAT2203 Preclinical Cryptococcal Meningitis Data in the American Society for Microbiology Journal, mBio
28/05/2019
– Efficacy of oral delivery of amphotericin B (MAT2203) demonstrated comparable efficacy to IV amphotericin, with similar survival of animals and reduction in fungal burden – – Cryptococcal meningitis is one of the most [...]
Spring Bank Pharmaceuticals to Present at Jefferies 2019 Global Healthcare Conference
28/05/2019
HOPKINTON, Mass., May 28, 2019 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, [...]
Catalyst Biosciences to Present at the Jefferies 2019 Global Healthcare Conference
28/05/2019
SOUTH SAN FRANCISCO, Calif., May 28, 2019 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO), today announced that Nassim Usman, Ph.D., president and chief executive officer of Catalyst Biosciences, will [...]
Progressive Care Inc. Announces Closing Date for Acquisition of Florida Pharmacies
28/05/2019
MIAMI, May 28, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, announced today the closing date of June 1, 2019 for the acquisition of Family [...]
CytomX Therapeutics to Present at Upcoming Healthcare Conferences
28/05/2019
SOUTH SAN FRANCISCO, Calif., May 28, 2019 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody [...]
IntelGenx Receives First Shipment of Cannabis Extract from Tilray® for Production of Cannabis-Infused Oral Film
28/05/2019
SAINT LAURENT, Quebec, May 28, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today provided an update on its cannabis-infused VersaFilm ® product [...]
Intellia Therapeutics Names Laura Sepp-Lorenzino, Ph.D., Chief Scientific Officer
28/05/2019
CAMBRIDGE, Mass., May 28, 2019 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc., (NASDAQ:NTLA) has named Laura Sepp-Lorenzino, Ph.D., as its new executive vice president and chief scientific officer. Dr. Sepp-Lorenzino [...]

Pages